Pages that link to "Q73698308"
Jump to navigation
Jump to search
The following pages link to T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis (Q73698308):
Displaying 30 items.
- Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system (Q24795134) (← links)
- Linking form to function: Biophysical aspects of artificial antigen presenting cell design (Q27002652) (← links)
- Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells (Q27026484) (← links)
- PTPN22 1858C>T (R620W) functional polymorphism and human longevity (Q28299415) (← links)
- Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors (Q34068188) (← links)
- Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions (Q34248531) (← links)
- Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation". (Q34367252) (← links)
- The promise and potential pitfalls of chimeric antigen receptors (Q34970378) (← links)
- Seatbelts in CAR therapy: How Safe Are CARS? (Q35818365) (← links)
- Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes (Q37109545) (← links)
- Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo (Q37436837) (← links)
- Chimeric antigen receptor T cells: a novel therapy for solid tumors (Q37728639) (← links)
- Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities (Q37741606) (← links)
- Chimeric antigen receptor-engineered T cells for immunotherapy of cancer (Q37751873) (← links)
- Tumor evasion from T cell surveillance (Q37970674) (← links)
- Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity. (Q38811497) (← links)
- Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling. (Q39360350) (← links)
- A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells (Q39381573) (← links)
- Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia (Q39718346) (← links)
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts (Q41085306) (← links)
- OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells (Q42060017) (← links)
- CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation (Q42143901) (← links)
- Carving the CAR. (Q45862461) (← links)
- Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center. (Q52369234) (← links)
- Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer. (Q55008640) (← links)
- Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. (Q55456683) (← links)
- Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells (Q90212066) (← links)
- Increased expression of the Cbl family of E3 ubiquitin ligases decreases Interleukin-2 production in a rat model of peripheral neuropathy (Q90318660) (← links)
- Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer (Q92348410) (← links)
- The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues (Q99546836) (← links)